文献速递中枢神经肿瘤放疗放疗物理与技术

Cullin2-RING E3连接酶作为胶质母细胞瘤预后与放射敏感性生物标志物

Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling.
PubMed 文献 · Radiother Oncol · 2020-09-10

该研究基于5个独立队列、超过3800例胶质瘤和GBM病例,分析CUL2表达及拷贝数变异与GBM进展、生存和放射敏感性的关系。结果显示CUL2表达可预测GBM进展和生存率,其蛋白水平与HIF-1α、VEGF-A、Cyclin B1和EGFR呈负相关,CUL2高表达预示放射敏感性增加和灌注成像信号强度减弱。CUL2表达受拷贝数变异调控,CUL2表达水平及拷贝数变异可作为GBM预后和放射敏感性分析的潜在生物标志物。

要点

  • CUL2表达可预测GBM进展和生存率。
  • Cullin2蛋白水平与HIF-1α、VEGF-A、Cyclin B1和EGFR呈负相关。
  • CUL2高表达预示放射敏感性增加和灌注成像信号强度减弱。

核心结论

  • CUL2表达水平及拷贝数变异可整合作为GBM预后和放射敏感性分析的潜在生物标志物。

研究设计与样本

  • 研究纳入来自5个独立队列的超过3800例胶质瘤和GBM病例,分析临床病理特征、影像、生存数据、RNA-Seq、拷贝数变异及其他遗传改变。

主要发现

  • CUL2表达可预测GBM进展和生存率。
  • Cullin2蛋白水平与HIF-1α、VEGF-A、Cyclin B1和EGFR呈负相关。
  • CUL2高表达预示放射敏感性增加和灌注成像信号强度减弱。
  • CUL2表达受拷贝数变异调控。

临床怎么用

  • CUL2表达水平及拷贝数变异可能用于GBM预后评估和放射敏感性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Positive epidermal growth factor receptor (EGFR) immunoreactivity in glioblastoma multiforme (GBM) often predicts poor radiation response. Meanwhile, all attempts to target EGFR pharmaceutically have been unsuccessful, mainly due to molecular heterogeneity of EGFR expression in GBM. A molecular biology-based and efficient way to access cellular protein levels of EGFR is urgently needed. EGFR, together with HIF-1α and Cyclin B1, is degraded via cullin2-RING E3 ligase (CRL2). It is worthwhile to investigate the possible involvement of CRL2 on GBM survival and radiosensitivity. MATERIALS AND METHODS: Clinicopathological features, radiographic images, survival data, RNA-Seq, copy number variations (CNVs), and other genetic changes were studied on over 3800 glioma and GBM cases, which are derived from 5 independent cohorts. These datasets include the Chinese Glioma Genome Atlas, The Cancer Genome Atlas, Ivy Glioblastoma Atlas Project, Clinical Proteomic Tumor Analysis Consortium, and the 2008 Parson's GBM dataset. RESULTS: Expression of CUL2, which encodes the scaffold protein cullin2 in the CRL2 E3 ligase, can predict GBM progression and survival rate. Cullin2 protein levels are inversely related to those of HIF-1α, VEGF-A, Cyclin B1, and EGFR. Elevated CUL2 expression predicts increased radiosensitivity and dampened signal intensities in perfusion imaging. CUL2 expression are regulated via CNVs, which are inheritable structural DNA variations. CONCLUSION: CUL2 expression levels and CNVs can be integrated as potential biomarkers in facilitating GBM and prognosis and radiosensitivity profiling.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Zheng S, Wu Y, Li Z, et al. Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling. Radiother Oncol. 2020. PMID: 32918970. doi:10.1016/j.radonc.2020.09.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。